Leveraging Machine Learning and Patient Reviews for Developing a Drug Recommendation System to Reduce Medical Errors

Author:

Swain K. P.,Mohapatra S.K.,Ravi Vinayakumar,Nayak Soumya Ranjan,Alahmadi Tahani Jaser,Singh Prabhishek,Diwakar Manoj

Abstract

Background In the rapidly evolving pharmaceutical industry, drug efficacy and safety stand as critical concerns. The vast accumulation of data, including customer feedback, drug popularity, and usage details, offers a rich resource for improving healthcare outcomes. Aims The primary aim of this study is to harness machine learning and Natural Language Processing (NLP) techniques to sift through extensive pharmaceutical data, identifying the most effective drugs for various conditions and uncovering patterns that could guide better decision-making in drug efficacy and safety. Objective This research seeks to construct a sophisticated model capable of analyzing diverse data points to pinpoint the most efficacious drugs for specific health conditions, thereby providing pharmaceutical companies with data-driven insights to optimize drug safety and effectiveness. Methods Employing a blend of Natural Language Processing (NLP) and machine learning strategies, the study analyzes a comprehensive dataset featuring customer reviews, drug popularity metrics, usage information, and other relevant data collected over an extended period. This methodological approach aims to reveal latent trends and patterns that are crucial for assessing drug performance. Results The developed model adeptly identifies leading medications for various conditions, elucidating efficacy and safety profiles derived from patient reviews and drug utilization trends. These findings furnish pharmaceutical companies with actionable intelligence for enhancing drug development and patient care strategies. Conclusion The integration of machine learning and NLP for the analysis of vast drug-related datasets presents a powerful method for advancing drug efficacy and safety. The insights yielded by the proposed model significantly empower the decision-making processes of the pharmaceutical industry, ultimately fostering improved health outcomes for patients.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3